SCHEMBL2776945

SCHEMBL2776945

Cc1cccc(SCCC(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.53
THRB P10828 1/20 0.53
ALDH1A1 P00352 4/20 0.51
HPGD P15428 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPK1 P28482 1/20 0.50
GAA P10253 1/20 0.48
HTT P42858 1/20 0.48
PRNP P04156 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
RXFP1 Q9HBX9 2/20 0.47
MAP2K7 O14733 1/20 0.46
CDC25A P30304 1/20 0.46
CDC25B P30305 1/20 0.46
PTGER1 P34995 1/20 0.46
PTGFR P43088 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
APEX1 P27695 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL27632756 0.94 ALDH1A1 (0.50) MAPTTHRBALDH1A1HPGDL3MBTL1
SCHEMBL21102257 0.87 ALDH1A1 (0.58) MAPTTHRBALDH1A1HPGDL3MBTL1
SCHEMBL3645531 0.86 ALDH1A1 (0.47) MAPTTHRBALDH1A1HPGDL3MBTL1
SCHEMBL11605014 0.83 ALDH1A1 (0.51) MAPTTHRBALDH1A1HPGDMAPK1
SCHEMBL10222036 0.82 APEX1 (0.64) ALDH1A1L3MBTL1GAACDC25BAPEX1
SCHEMBL2775739 0.82 ALDH1A1 (0.47) MAPTTHRBALDH1A1HPGDL3MBTL1
SCHEMBL9334773 0.82 GAA (0.45) MAPTTHRBALDH1A1HPGDMAPK1
SCHEMBL30753697 0.81 ALDH1A1 (0.50) MAPTALDH1A1HPGDL3MBTL1MAPK1
SCHEMBL13948874 0.81 MAPT (0.51) MAPTALDH1A1HPGDL3MBTL1MAPK1
SCHEMBL22714458 0.81 ALDH1A1 (0.53) ALDH1A1HPGDPRNPNPSR1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115836077-B Oxazaspiro derivative, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2025-05-13 CN disclosed
US-20230234962-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2023-07-27 US disclosed
US-20230234962-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2023-07-27 US disclosed
US-20230234962-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2023-07-27 US disclosed
CN-113754685-B Dihydrothiochromene pyrazole derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2023-06-16 CN disclosed
EP-4190789-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2023-06-07 EP disclosed
EP-4190789-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2023-06-07 EP disclosed
CN-115836077-A Oxaazaspiro derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-03-21 CN disclosed
CN-115835863-A Oxaazabicyclic derivatives, preparation method and application thereof in medicines 江苏恒瑞医药股份有限公司 2023-03-21 CN disclosed
WO-2022022630-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 2022-02-03 WO disclosed
CN-1692108-A Heterocyclic pesticides FMC CORP (US) 2005-11-02 CN disclosed
EP-1499609-A4 PESTICIDAL HETEROCYCLES FMC CORP (US) 2005-09-14 EP disclosed
US-20050143418-A1 Pesticidal heterocycles FMC CORPORATION 2005-06-30 US disclosed
EP-1499609-A2 PESTICIDAL HETEROCYCLES FMC CORPORATION (US) 2005-01-26 EP disclosed
WO-2003092374-A2 PESTICIDAL HETEROCYCLES FMC CORPORATION (US) 2003-11-13 WO disclosed
US-5886016-A ANTIINFLAMMATORY AGENT WITH MINIMAL SIDE EFFECTS FOR TREATING ARTHRITIS G.D. SEARLE & CO. (US) 1999-03-23 US disclosed
US-5670532-A Pyrazolyl derivatives for the treatment of inflammation G. D. SEARLE & CO. (US) 1997-09-23 US disclosed
US-5565482-A ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS G.D. SEARLE & CO. (US) 1996-10-15 US disclosed
US-5547975-A ANTIARTHRIC AGENTS, ANALGESICS AND ANTIPYRETICS; INHIBITORS OF CYCLOOXYGENASE II; SIDE EFFECT REDUCTION G.D. SEARLE & CO. 1996-08-20 US disclosed
WO-1996009304-A1 BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234962-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF PIK3CD, PIK3CA, PIK3R5 MAPT 4389/4885THRB 1946/4885ALDH1A1 704/4885
US-20050143418-A1 Pesticidal heterocycles DDT, TRHR, ACHE MAPT 1775/4885THRB 257/4885ALDH1A1 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.